April 2014

Cyberonics names Rohan Hoare COO, O’Neill D’Cruz CMO

Wednesday, April 30, 2014

Cyberonics, a medical technology company, has promoted Rohan Hoare, Ph.D., to the newly created role of chief operating officer. Rohan will be responsible for the development, manufacturing, quality and commercial activities for the Epilepsy franchise. The company also announced that O’Neill F. D’Cruz, M.D. recently joined the company as chief medical officer.

[Read More]

New Canadian Clinical Trials Coordinating Center launched

Wednesday, April 30, 2014

The Canadian government has created a Canadian Clinical Trials Coordinating Center (CCTCC)—a collaborative effort of the Canadian Institutes of Health Research (CIHR), Canada’s Research-Based Pharmaceutical Companies (Rx&D) and the merged organizations of the Association of Canadian Academic Healthcare Organizations and the Canadian Healthcare Association (ACAHO/CHA). The CCTCC will be housed at the offices of the Health Charities Coalition of Canada in Ottawa.

[Read More]

Adaptive Clinical expands Asia Pacific operations, establishes Singapore location

Wednesday, April 30, 2014

CRO Adaptive Clinical Systems has expanded its eClinical Integration Platform services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. The company has established a regional hub in Singapore to better enable the industry’s growing need to conduct clinical trials in Asia and manage global trials from the region. 

[Read More]

Wisconsin awards grant to Bridge to Cures to commercialize university R&D

Wednesday, April 30, 2014

In an effort to deliver the benefits of medical discovery to patients seeking relief, the Wisconsin Economic Development Corporation (WEDC) has awarded a $140,000 grant to Bridge to Cures (B2C), a new nonprofit, to establish a new seed fund. The matching grant will enable B2C to provide seed money to entrepreneurs at academic institutions in southeastern Wisconsin seeking to translate their medical research and inventions into products and companies in the healthcare space.

[Read More]